Literature DB >> 1386701

The new cyclosporine derivative, SDZ IMM 125: in vitro and in vivo pharmacologic effects.

P C Hiestand1, M Gräber, U Hurtenbach, P Herrmann, S Cammisuli, B P Richardson, M K Eberle, J F Borel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1386701

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

Review 1.  Perspectives in pharmacokinetics. Physiologically based pharmacokinetic modeling as a tool for drug development.

Authors:  S B Charnick; R Kawai; J R Nedelman; M Lemaire; W Niederberger; H Sato
Journal:  J Pharmacokinet Biopharm       Date:  1995-04

Review 2.  New immunosuppressive agents for pediatric transplantation.

Authors:  M Ferraresso; B D Kahan
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

3.  Effects of immunomodulators on airways hyperresponsiveness to adenosine induced in actively sensitised Brown Norway rats by exposure to allergen.

Authors:  Bruno Tigani; Jason P Hannon; Elisabeth Schaeublin; Lazzaro Mazzoni; John R Fozard
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-06-24       Impact factor: 3.000

4.  Physiologically based pharmacokinetic study on a cyclosporin derivative, SDZ IMM 125.

Authors:  R Kawai; M Lemaire; J L Steimer; A Bruelisauer; W Niederberger; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1994-10

5.  In vitro biosynthesis of ring-extended cyclosporins.

Authors:  A Lawen; R Traber; R Reuille; M Ponelle
Journal:  Biochem J       Date:  1994-06-01       Impact factor: 3.857

6.  Isolation, identification and immunosuppressive activity of SDZ-IMM-125 metabolites from human liver microsomes.

Authors:  R Dieden; R K Verbeeck; D Latinne; P Wallemacq; N Maton; G J Lhoest
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1999 Jan-Mar       Impact factor: 2.569
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.